|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, May 09, 2008 ) New York – DermaPlus, Inc. recently announced the results of a third- party study proving participants applying DermaLastyl anti-aging skin cream had up to a 45% reduction in crow’s feet. These results were confirmed using the most sophisticated measurement technology available: before and after computer analyzed digital photographs, and an in-vivo skin profiling system.
“Thirty-five subjects with visibly fine lines around the eye area participated in the 12-week study using our DermaLastyl anti-aging cream. The study was performed under the supervision of Dr. Steven Lamm, the ‘house doctor’ on The View TV show. They were provided with a supply of the DermaLastyl along with instructions for use and were then imaged with a VISIA CR 2-D Digital Imaging Booth and a PRIMOS 3-D Profilometry Optical Imaging system operated by Canfield Scientific, Inc. The subjects returned after
6 weeks and again in 12 weeks for follow-up digital and profilometry imaging and evaluation. The final results documented up to a 45% reduction in skin roughness in the crow’s feet area around the eyes. Now we have irrefutable evidence to support our efficacy claims. A copy of the study is available and will be emailed to interested parties,” notes Dr. Burt Ensley, CEO DermaPlus, Inc.
DermaLastyl is the first cosmetic product ever to contain a completely functional human protein, Elastatropin, a synthetic form of natural elastin. Elastin, the second most abundant protein in the skin, is responsible for the elasticity of skin and organs, and its degradation is a well-known irreversible cause of wrinkles.
DermaLastyl is not yet available in stores but can be purchased online at http://www.dermalastyl.com/ or by calling 800-335-8312. Distribution will be expanded to include retail and department stores worldwide in the coming months.
About DermaPlus, Inc.
DermaPlus, Inc., the producer of DermaLastyl line of products, is a biotechnology company that designs and manufactures sophisticated, high performance biomaterials for use in cosmeceuticals. Based on human genetic sequences, these biomaterials can be customized to reflect the genetic makeup of human tissues, population groups or even single individuals. DermaLastyl-B, DermaLastyl-E, DermaLastyl-Bx, and DermaLastyl-Ex are the first genetically engineered products on the market that help restore elastin properties to the skin. Used properly, DermaLastyl will eliminate and/or prevent wrinkles, reducing the need or extending the life of cosmetic medical procedures such as for Botox or facelifts.
Media Contact:
Jerry Jennings
Emerson Gerard Associates
561-881-7318
mediareply@emersongerard.com
###
This press release was issued through GroupWeb EmailWire.Com. For more information on unlimited press release distribution for $499/year, go to http://www.emailwire.com
DermaLastyl
Jerry Jennings
561-881-7318
mediareply@egaplus.com 
Source: EmailWire.com
|
|
|
|
